medigraphic.com

2017, Number S1

<< Back Next >>

Rev Mex Anest 2017; 40 (S1)

Anesthesia in hepatectomy: is the anesthetic procedure a determining factor?

Cuellar-Guzmán LF, Mille-Loera JE, Alvarado-Pérez J, García-Velasco O, Fabela-Barragán JA

Language: Spanish
References: 27
Page: 120-125
PDF size: 170.82 Kb.


Text Extraction

No abstract.


REFERENCES

  1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet].

  2. Damico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2010;44:217-231.

  3. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 2009;19:329-338.

  4. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:698-711.

  5. Guglielmi A, Ruzzenente A, Pachera S, Valdegamberi A, Sandri M, D’Onofrio M, et al. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol. 2008;103:597-604.

  6. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200.

  7. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.

  8. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850-855.

  9. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908-1916.

  10. Arii S, Tanaka S, Mitsunori Y, Nakamura N, Kudo A, Noguchi N, et al. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology. 2010;78:125-130.

  11. Miller RD. Miller’s Anesthesia, Vol. 1, 7th ed. Barcelona, Elsevier, 2010, pp. 183-185.

  12. Patel T. Surgery in the patient with liver disease. Mayo Clin Proc. 1999;74:593-599.

  13. Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM, et al. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery. 1992;112:891-896.

  14. Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol. 2012;4:266-276.

  15. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;2:1208-1236.

  16. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243:373-379.

  17. Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71-78.

  18. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-1022.

  19. Allan N, Siller C, Breen A. Anesthetic implications of chemotherapy. Contin Educ Anaesth Crit Care Pain. 2012;12:52-58.

  20. Spolverato G, Ejaz A, Kim Y, Hall BL, Bilimoria K, Cohen M, et al. Patterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-tergeted hepatectomy database. J Surg Res. 2015;196:221-228.

  21. Jaffe RA, Schmiesing CA, Golianu B. Anesthesiologist’s Manual of Surgical Procedures, 5th ed. Philadelphia, Lippincott Williams & Wilkins 2014, pp. 564-569.

  22. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936.

  23. Hartog A, Mills G. Anesthesia for hepatic resection surgery. Contin Educ Anaesth Crit Care Pain 2009;9:1-5.

  24. Pape A, Meier J, Kertscho H, Steche M, Laout M, Schwerdel F, et al. Hyperoxic ventilation increases the tolerance of acute normovolemic anemia in anesthetized pigs. Crit Care Med. 2006;34:1475-1482.

  25. Meier J, Kemming G, Kisch-Wedel H, Wölkhammer S, Habler OP. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology. 2004;100:70-76.

  26. Moug S, Smith D, Leen E. Eur J Surg Oncol. 2007;33:1036-1042.

  27. Jarnagin W, Gonen M, Maithel SK, Fong Y, D’Angelica MI, Dematteo RP, et al. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg. 2008;248:360-369.




2020     |     www.medigraphic.com